COPD Highlights vom ATS Kongres 2020
-Diagnosis
Risk assessment through airway counting
Analysis of hyperinflation from spirometry
Prognosis - role of reduced DLCO
- Comorbidities - cardiovascular system diastolic dysfunction and
> hospital admissions
> pulmonary dysfunction
- Muscle assessment using CT
- antibodies against pneumococci and exacerbations
- pharmacological treatment
> LABA / LAMA vs single substances and short vs long-term effects
> Triple vs LABA / ICS vs LABA / LAMA - ETHOS
> LABA / LAMA vs LABA / ICS and LABA / LAMA vs LABA / LAMA / ICS
